Methyl 1-(3-chlorophenyl)-4-oxocyclohexanecarboxylate

Catalog No.: 
ACLYWI328
CAS No.: 
1384264-35-0
Molecular Formula: 
C14H15ClO3
Molecular Weight: 
266.72
Methyl 1-(3-chlorophenyl)-4-oxocyclohexanecarboxylate structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
100mg95%$222.00InquiryInquiry
250mg95%$402.00InquiryInquiry
1g95%$826.00InquiryInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product NameMethyl 1-(3-chlorophenyl)-4-oxocyclohexanecarboxylate
IUPAC Namemethyl 1-(3-chlorophenyl)-4-oxocyclohexane-1-carboxylate
MDL No.MFCD22423116
Molecular FormulaC14H15ClO3
Molecular Weight266.72
SMILESO=C(C1(C2=CC=CC(Cl)=C2)CCC(CC1)=O)OC
InChI KeyFRYJJWMYIVZUMG-UHFFFAOYSA-N
SynonymMETHYL 1-(3-CHLOROPHENYL)-4-OXOCYCLOHEXANECARBOXYLATE;Cyclohexanecarboxylic acid, 1-(3-chlorophenyl)-4-oxo-, methyl ester;methyl 1-(3-chlorophenyl)-4-oxocyclohexane-1-carboxylate
CAS No.1384264-35-0

Safety Data

Pictogram
Harmful or irritant
Signal Word
Warning
Hazard Statement(s)
H302-H315-H319-H335
Precautionary Statement(s)
P261-P280-P301+P312-P302+P352-P305+P351+P338

Synthetic Route by SureRoute

1. ACLYWI328 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACQVKH312 route compound structure diagram
    ACQVKH3121184-54-9In Stock
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACLYWI328 route product structure diagram
    ACLYWI3281384264-35-0
Inquiry

2. ACLYWI328 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Then
  3. ACLYWI328 route product structure diagram
    ACLYWI3281384264-35-0
Inquiry

3. ACLYWI328 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Then
  3. ACLYWI328 route product structure diagram
    ACLYWI3281384264-35-0
Inquiry

Comments (0)